Wall J., Ratcliffe W.A., Howell A.,
è ñîàâò. Response to intravenous bisphosphonate
therapy in hypercalcaemic patients with and without bone metastases: The role of parathy
roid hormone related protein // Br. J. Cancer. — 1994. — V. 70. — P. 169 172.
Walls J., Bundred N., Howell A.
Hypercalcemia and bone resorption in malignancy
// Clin. Orthop. — 1995. — V.312. — P. 51 63.
Walls J., Assiri A., Howell A., Rogers E., Ratcliffe W.A., Eastell R., Bundred N.J.
Measurement of urinary collagen cross links indicate response to therapy in patients with
breast cancer and bone metastases // Br. J. Cancer. — 1999. — V. 80(8). — P. 1265 1270.
Walne A.J., Jenkins P.J., James I.T., Plowman P.N
. Pyridinium crosslinks in the
monitoring of patients with bone metastases from carcinoma of the breast // Clin. Oncol.
(R. Coll. Radiol.). — 1997. — V. 9(1). — P. 30 34.
Wedin R., Bauer H.C., Wersall P.
Failures after operation for skeletal metastatic
lesions of long bones // Clin. Orthop. — 1999. — V. 358. — P. 128 139.
Weiss L., Gilbert H.A.
Bone metastases // Boston: G.K.Hall. — 1981. — 360 p.
Weiss L.K., White J.J., Kau T.Y.,
è ñîàâò. Impact of micrometastases on the survival
of women with T1 breast cancer // Program and abstracts of 22nd San Antonio Breast
Cancer Symposium; December 8 11, 1999; San Antonio, Texas. Abstract 10.
Werner B., Isacson C., Lundell G.
P32 pyrophosphate in treatment of persistent
metastatic bone pain // Acta Radiolog. Oncol. — 1980. — V.19 (fasc.). — P. 327 329.
Werther K., Brunner N.A., Nielsen H.J.
Can detection of cancer cells in bone marrow
and peripheral blood be used in diagnosis and patient monitoring? // Ugeskr. Laeger. —
1998. — V. 160(41). — P. 5923 5926.
Whitehouse J.M.A.
Site dependent response to chemotherapy for carcinoma of the
breast // J. R. Soc. Med. — 1985. — V. 78 (Suppl. 9). — P.18 22.
Willen H.
Fine needle aspiration in the diagnosis of bone tumors // Acta Orthop.
Scand .Suppl. — 1997. — V. 273. — P. 47 53.
Willis R.A.
The spread of tumors in human body // London: Butterworth and Co. —
1973.
Wood P. J., Sokolowsky G.
Radioimmunoassay in theory and practice (A handbook
for Laboratory Personal) // Frankfurt on Main: Schnetzor Verlag, 1981. — 154 p.
Woodruff R.
Palliativ Medicine. Symptomatic and supportive Care for Patients with
Advanced Cancer and AIDS // Melbourn: Asperula Pty Ltd, 1993. — ch. 20. — P. 255 258.
Yadav G.C., Rao A., Motawy M.M., Safadi N., Ahmed M.J.
CA 15.3 with urinary cal
cium excretion is useful in the diagnosis and monitoring of bone metastases from breast
cancer // Int. J. Biol. Markers. — 1993. — V. 8(4). — P. 208 214.
Yamamoto I., Morita R., Konishi J., Shigeno C., Ikekubo K., Hino M., Sone T.,
Fujimoto R.
Clinical studies using measurement of N telopeptides of type 1 collagen (NTx)
in patients with bone metastasis—comparison with bone scintigraphy and other metabolic
bone markers // Kaku Igaku. — 1995. — V. 32(5). — P 501 510.
Yamamoto I., Miura H., Kigami Y., Yamamura Y., Ohta T., Yuu I., Yamamoto Y.,
Morita R..
Detection of bone metastasis by serial measurement of C terminal telopeptide
of type I collagen in patients with malignancy // Kaku Igaku. — 1996. — V. 33(4). — P.
423 429.
Yamashita K., Koyama H., Inaji H.
Prognostic significance of bone metastasis from
breast cancer // Clin. Orthop. — 1995. — V. 312. — P. 89 94.
Yasasever V., Dincer M., Camlica H., Karaloglu D., Dalay N.
Utility of CA 15 3 and
CEA in monitoring breast cancer patients with bone metastases: special emphasis on «spik
ing» phenomena // Clin. Biochem. — 1997. — V. 30(1). — P. 53 56.
254
Êîñòíûå ìåòàñòàçû ðàêà ìîëî÷íîé æåëåçû
